JPRN-UMIN000009906
Completed
Phase 2
Safety and Clinical Outcomes of Percutaneous Cryoablation for Musculoskeletal Tumor: a Phase-II Clinical Study - Percutaneous Cryoablation for Musculoskeletal Tumor
Department of Radiology, Mie University School of Medicine0 sites20 target enrollmentJanuary 30, 2013
Conditionsmusculoskeletal tumor
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- musculoskeletal tumor
- Sponsor
- Department of Radiology, Mie University School of Medicine
- Enrollment
- 20
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Exclusion criteria is an abnormal coagulability as defined by platelet count of less than 50,000/mm3, and an international normalized ratio (INR) of greater than 1\.5\.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Safety and Efficacy of Percutaneous Cryoablation for Thoracic MalignanciesPrimary lung cancer, metastatic lung cancer, mediastinal tumor, chest wall tumorJPRN-UMIN000014996School of Medicine, Keio University200
Completed
Not Applicable
Safety cofirmatory study for Percutaneous cryoablation of vascular malformationsvascular malformationJPRN-UMIN000012194Okayama University Hospital9
Completed
Phase 1
Safety of Percutaneous Cryoablation in Patients with Painful Bone and Soft Tissue Tumors: A Single Center Prospective Study (SCIRO-1502)Painful bone and soft tissue tumorJPRN-UMIN000019077Okayama University Hospital10
Not yet recruiting
Not Applicable
Safety and feasibility of the use of cryoablation in patients with brain neoplasmbrain neoplasmbrain tumors1002765610019190NL-OMON53649Erasmus MC, Universitair Medisch Centrum Rotterdam30
Completed
Phase 1
Phase 1 Clinical Trial of Percutaneous Cryoablation for Painful Musculoskeletal TumorPainful Muscloskeletal tumor (osteoid osteoma, metastatic MSK tumor)JPRN-UMIN000027828Gunma University Hospital18